Rheumatoid Arthritis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Lilly scraps rheumatoid arthritis trial after interim review | FierceBiotech - FierceBiotech



FierceBiotech
 
Lilly scraps rheumatoid arthritis trial after interim review | FierceBiotech 
FierceBiotech
Eli Lilly has halted a phase 2 rheumatoid arthritis trial after getting a midstudy glimpse at the data. The setback leaves Lilly and partner Hanmi Pharmaceutical to weigh whether it is worth moving the Bruton's TKI forward in other indications.

and more » 


Rheumatoid Drug No Help To Arthritis Patients - WebMD



Rheumatoid Drug No Help To Arthritis Patients 
WebMD
WEDNESDAY, Feb. 21, 2018 (HealthDay News) -- A malaria drug that's also shown effectiveness against rheumatoid arthritis pain has failed to help people with the more common form of arthritis, new research shows. The drug is called Plaquenil ...

and more » 


CVS Health targets rheumatoid arthritis efficacy - Employee Benefit Adviser



Employee Benefit Adviser
 
CVS Health targets rheumatoid arthritis efficacy 
Employee Benefit Adviser
Rheumatoid Arthritis costs the U.S. more than $19 billion annually, accounting for nearly half of the overall specialty drug trend for the first half of 2017 for CVS Health's pharmacy benefit management clients. In response to the growing cost and ...

 


Eli Lilly shutters a failed PhII for rheumatoid arthritis, clouding $690M Hanmi pact - Endpoints News



Endpoints News
 
Eli Lilly shutters a failed PhII for rheumatoid arthritis, clouding $690M Hanmi pact 
Endpoints News
Eli Lilly $LLY has just shuttered a Phase II trial for an experimental Bruton's TKI inhibitor for rheumatoid arthritis after concluding that the nearly two-year-old study was going down in flames. Lilly hasn't put out any word on the trial failure, but ...

 


10 of the best apps for rheumatoid arthritis in 2018 - Medical News Today



Medical News Today
 
10 of the best apps for rheumatoid arthritis in 2018 
Medical News Today
Rheumatoid arthritis can significantly affect everyday life. We have found the best apps to help manage the associated pain and symptoms of the condition.

and more » 


Diagnosis of Rheumatoid Arthritis May Vary According to Specific Assay Used - Rheumatology Advisor



Rheumatology Advisor
 
Diagnosis of Rheumatoid Arthritis May Vary According to Specific Assay Used 
Rheumatology Advisor
Technical differences in various diagnostic tests for rheumatoid arthritis may affect the diagnosis of rheumatoid arthritis. Rheumatoid arthritis (RA) classification according to the 2010 American College of Rheumatology/European League Against ...

 


Bowen Becker fights through rheumatoid arthritis to thrive with Minnesota - Minnesota Daily



Minnesota Daily
 
Bowen Becker fights through rheumatoid arthritis to thrive with Minnesota 
Minnesota Daily
Becker couldn't play any other sports because of rheumatoid arthritis in his knees. He said his condition does not make life for him more difficult, except when training for his Division I sport. "It impacts the way I look into athletics and how I work ...

 


What Kind of Rheumatoid Arthritis Patient Are You? - Everyday Health, Inc. (blog)



Everyday Health, Inc. (blog)
 
What Kind of Rheumatoid Arthritis Patient Are You? 
Everyday Health, Inc. (blog)
The words themselves are simple, but given the number of treatment options now available, the approach to helping patients meet specific treatment goals can become complicated. Over the past couple of decades, the growing availability of biologic and ...

 


Rheumatoid Arthritis Drugs Market Worth $30.4 Billion by 2025 ... - PR Newswire (press release)



The Pharma Letter
 
Rheumatoid Arthritis Drugs Market Worth $30.4 Billion by 2025 ... 
PR Newswire (press release)
The global rheumatoid arthritis therapeutics market size is expected to reach USD 30.4 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.6% during the forecast period. Some of the key trends driving the ...
Rheumatoid arthritis drugs market will grow to $30.4 billion by 2025 The Pharma Letter

all 2 news articles » 


Gene expression study may help guide Arthritis care - Medical Xpress



Medical Xpress
 
Gene expression study may help guide Arthritis care 
Medical Xpress
Researchers who analyzed gene expression in synovial tissue samples from rheumatoid arthritis patients' joints identified different patterns that may be clinically meaningful. The findings, which are published in Arthritis & Rheumatology, indicate that ...

and more »